{"title":"额颞叶痴呆:临床特征和治疗。","authors":"Tiffany W Chow","doi":"10.1053/scnp.2003.50000","DOIUrl":null,"url":null,"abstract":"<p><p>This 2-part review of the frontotemporal lobar degeneration (FTLD) begins with an outline of clinical features, which differentiate FTLD from Alzheimer's disease, the more common cause of dementia. The second part describes interventions for FTLD. Although there is currently no disease-modifying therapeutic agent, symptomatic pharmacotherapy helps to control the marked mood and behavioral disturbances that may distinguish this syndrome from other causes of dementia.</p>","PeriodicalId":79723,"journal":{"name":"Seminars in clinical neuropsychiatry","volume":"8 1","pages":"58-70"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"Frontotemporal dementias: clinical features and management.\",\"authors\":\"Tiffany W Chow\",\"doi\":\"10.1053/scnp.2003.50000\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This 2-part review of the frontotemporal lobar degeneration (FTLD) begins with an outline of clinical features, which differentiate FTLD from Alzheimer's disease, the more common cause of dementia. The second part describes interventions for FTLD. Although there is currently no disease-modifying therapeutic agent, symptomatic pharmacotherapy helps to control the marked mood and behavioral disturbances that may distinguish this syndrome from other causes of dementia.</p>\",\"PeriodicalId\":79723,\"journal\":{\"name\":\"Seminars in clinical neuropsychiatry\",\"volume\":\"8 1\",\"pages\":\"58-70\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in clinical neuropsychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1053/scnp.2003.50000\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in clinical neuropsychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1053/scnp.2003.50000","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Frontotemporal dementias: clinical features and management.
This 2-part review of the frontotemporal lobar degeneration (FTLD) begins with an outline of clinical features, which differentiate FTLD from Alzheimer's disease, the more common cause of dementia. The second part describes interventions for FTLD. Although there is currently no disease-modifying therapeutic agent, symptomatic pharmacotherapy helps to control the marked mood and behavioral disturbances that may distinguish this syndrome from other causes of dementia.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
